Mass Balance Study of the Engineered Cationic Antimicrobial Peptide, WLBU2, Following a Single Intravenous Dose of 14C-WLBU2 in Mice

BACKGROUND: To address multidrug resistance, we developed engineered cationic antimicrobial peptides (eCAPs). Lead eCAP WLBU2 displays potent activity against drug-resistant bacteria and effectively treats lethal bacterial infections in mice, reducing bacterial loads to undetectable levels in divers...

Ful tanımlama

Kaydedildi:
Detaylı Bibliyografya
Yayımlandı:Curr Rev Clin Exp Pharmacol
Asıl Yazarlar: Beumer, Jan H., Guo, Jianxia, Ray, Evan C., Scemama, Jonas, Parise, Robert A., Deslouches, Berthony, Steckbeck, Jonathan D., Montelaro, Ronald C., Eiseman, Julie L.
Materyal Türü: Artigo
Dil:Inglês
Baskı/Yayın Bilgisi: 2021
Konular:
Article
Online Erişim:https://ncbi.nlm.nih.gov/pmc/articles/PMC8083974/
https://ncbi.nlm.nih.gov/pubmed/32778037
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.2174/1574884715666200810094201
Etiketler: Etiketle
Etiket eklenmemiş, İlk siz ekleyin!

Benzer Materyaller